Search

everythinglearnresearchcommunity

for

Search:↓

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Early hormones shape sex-specific differences in rat glands.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

Genetic variants in CYP genes may worsen PCOS symptoms.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

A new gene, JMJD1C, may affect testosterone levels in men.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Hidradenitis suppurativa improves with antiandrogen therapy.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

New genes and pathways are important for testosterone production and male sexual development.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Lower ghrelin levels and certain gene variations may increase acne risk.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.